ArticleOncology letters2024

Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes.

Ikko Tomisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.